is retatrutide approved 2025 vs tirzepatide for weight loss Lilly orforglipron oral GLP-1 phase

[DOI] [PubMed] [Google Scholar] [18].Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ, IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045, Diabetes Res Clin Pract 183 (2022) 109119

In late 2023, tirzepatide (brand name Mounjaro) surpassed dulaglutide (brand name Trulicity) as the second most commonly prescribed ADM

Pediatr Diabetes 2009;10 Suppl 12:17-32.ArticlePubMed 66

This is important especially in the pediatric population, to have close follow-up with dietitian

These products are not drugs, foods, cosmetics, diagnostic products, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use